
Australian drugmaker Telix Pharmaceuticals is acquiring Germany's ITM Isotope Technologies Munich in a deal worth about 1.65 billion dollars. The merger will combine large scale radioisotope production with cancer drug development.
.jpg%3Fwidth%3D800&w=3840&q=75)
World · Sep 26 · L1-L4

Science · Sep 26 · L1-L4